Literature DB >> 23821504

Lung transplantation for obstructive lung diseases.

Rupal J Shah1, Robert M Kotloff.   

Abstract

Chronic obstructive pulmonary disease (COPD) represents one of the most common indications for lung transplantation, accounting for approximately one third of all procedures performed worldwide to date. Despite this extensive experience, questions remain about the appropriate timing of transplantation in the natural history of COPD, the optimal procedure to perform, and the survival benefit achieved. Less commonly encountered obstructive lung disorders for which transplantation is occasionally performed include emphysema due to α-1-antitrypsin deficiency, lymphangioleiomyomatosis, and Langerhans cell histiocytosis. Like COPD, the application of transplantation to these rare disorders also poses several questions. This article explores issues that arise when lung transplantation is utilized for treatment of both common and uncommon obstructive lung disorders. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23821504     DOI: 10.1055/s-0033-1348468

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  6 in total

Review 1.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

Review 2.  Lung transplantation: a treatment option in end-stage lung disease.

Authors:  Marc Hartert; Omer Senbaklavacin; Bernhard Gohrbandt; Berthold M Fischer; Roland Buhl; Christian-Friedrich Vahld
Journal:  Dtsch Arztebl Int       Date:  2014-02-14       Impact factor: 5.594

Review 3.  Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions.

Authors:  Faisal M Siddiqui; Joshua M Diamond
Journal:  Curr Opin Pulm Med       Date:  2018-03       Impact factor: 3.155

4.  Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension.

Authors:  Peter Rymkiewicz; Pietro Ravani; Brenda R Hemmelgarn; Finlay A McAlister; Danielle A Southern; Robin Walker; Guanmin Chen; Hude Quan
Journal:  BMC Health Serv Res       Date:  2016-11-22       Impact factor: 2.655

5.  In Vitro and In Vivo Feasibility Study for a Portable VV-ECMO and ECCO2R System.

Authors:  Lasse J Strudthoff; Hannah Lüken; Sebastian V Jansen; Jan Petran; Peter C Schlanstein; Lotte Schraven; Benjamin J Schürmann; Niklas B Steuer; Georg Wagner; Thomas Schmitz-Rode; Ulrich Steinseifer; Jutta Arens; Rüdger Kopp
Journal:  Membranes (Basel)       Date:  2022-01-22

Review 6.  Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations.

Authors:  C Randall Lane; Adriano R Tonelli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.